SHLT SHL Telemedicine
- 4.650
- +0.000+0.01%
SHL Telemedicine News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersCyclacel Pharmaceuticals (NASDAQ:CYCC) stock moved upwards by 50.0% to $2.04 during Tuesday's pre-market session. The company's market cap stands at $2.6 million. GeneDx Hldgs (NASDAQ:WGS) shar
When Will SHL Telemedicine Ltd. (VTX:SHLTN) Breakeven?
SHL Telemedicine Full Year 2023 Earnings: US$0.43 Loss per Share (Vs US$0.005 Loss in FY 2022)
SHL Telemedicine Reports Revenue Growth Amid Expansion
Express News | SHL Telemedicine FY Net Loss $(6.9)M Vs. $(0.4)M YoY
Express News | SHL Telemedicine FY Sales $57.1M Up From $55.4M YoY
Press Release: SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones
In 2023, SHL Telemedicine achieved key highlights, underscoring its global market strength.
SHL Telemedicine Reports Wider FY23 Attributable Loss
SHL Telemedicine (SHLTN.SW) on Wednesday reported a wider loss for 2023, while revenue fell year over year. Net loss attributable to equity holders for the 12 months ended Dec. 31, 2023, was $7.1 mill
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersClene (NASDAQ:CLNN) shares moved upwards by 54.9% to $0.48 during Tuesday's after-market session. The company's market cap stands at $61.6 million. Talphera (NASDAQ:TLPH) shares moved upwards b
Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine's SmartHeart in Post-ACS Patient Care
Groundbreaking Study reveals a 76% drop in hospital readmissions and a 41% decrease in Emergency Department visits, underscoring SHL and SmartHeart's pivotal role in remote cardiac care SHL Telemedicine Ltd.
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersLongeveron (NASDAQ:LGVN) shares moved upwards by 75.0% to $3.85 during Monday's pre-market session. The market value of their outstanding shares is at $9.6 million. PetVivo Hldgs (NASDAQ:PETV)
SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)--$SHLT--SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN; NASDAQ: SHLT) ("SHL" or the "Company"), a leading provider and developer of advanced per
SHL Telemedicine Announces Shareholders Meeting
SHL Telemedicine Initiated at Buy by Litchfield Hills
SHL Telemedicine Initiated at Buy by Litchfield Hills
Express News | Litchfield Hills Initiates Coverage On SHL Telemedicine With Buy Rating, Announces Price Target of $11
SHL Telemedicine Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/14/2024 74.6% Litchfield Hills → $11 Initiates Coverage On → Buy
Bullish SHL Telemedicine Insiders Loaded Up On US$686.7k Of Stock
Imperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicine's SmartHeart Technology, to Be Presented at ACC 24
The selection of the TELE-ACS trial results for presentation at ACC 24 highlights the pioneering achievements of Imperial College London and SHL in advancing the field of telemedicine SHL Telemedicine Ltd.
Following a 53% Decline Over Last Year, Recent Gains May Please SHL Telemedicine Ltd. (VTX:SHLTN) Institutional Owners
SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024
SHL Telemedicine German Operation and BARMER, one of the top health insurance funds in Germany, to present at leading Germany Healthcare ConferenceTEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)
Analysis
Price Target
No Data
